Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Sebaceous neoplasms and the immunoprofile of mismatch-repair proteins as a screening target for syndromic cases

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Establishment of digital cutoff values for intraepithelial lymphocytes in biopsies from colonic mucosa with lymphocytic colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sessile serrated lesion and its borderline variant - Variables with impact on recorded data

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Biopsies of colorectal clinical polyps--emergence of diagnostic information on deeper levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Phospho-ERK levels as predictors for chemotherapy of rectal carcinoma

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. CD3 immunohistochemical staining in diagnosis of lymphocytic colitis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

INTRODUCTION: Muir-Torre syndrome (MTS), a subset of Lynch syndrome, is characterized by concurrent or sequential development of sebaceous neoplasms, and internal malignancies, specifically colorectal carcinoma (CRC), and can be related to mismatch-repair (MMR)-protein deficiency. In CRC context, p16-negativity in MLH1-deficient cases may denote methylation rather than mutation. The prime aim of this study was to evaluate the mismatch-repair (MMR)-protein deficiency and the p16 status among sebaceous neoplasms.

MATERIAL AND METHOD: From January 1990 through October 2012, 26 sebaceous adenomas (SAs) and 6 sebaceous carcinomas (SCs) were accrued. The expression of MLH1, MSH2, MSH6, and PMS2 was recorded. MLH1-deficient cases were tested for p16 status.

RESULTS: Eighteen (56%) of the 32 specimens with SA or SC displayed MMR-protein deficiency, comprising 17 (65.4%) SAs (MSH2/MSH6 loss in 12, MLH1/PMS2 loss in 3, MSH6 loss only in 2 cases) and 1 (16.7%) SC (MLH1/PMS2 loss). All 4 MLH1 deficient cases were p16-positive.

CONCLUSION: A substantial proportion of sebaceous neoplasms were MMR-protein deficient and thus likely MTS candidates. Given the low prevalence of sebaceous neoplasms in Denmark, immunohistochemistry for the four MMR-proteins is recommended in the initial diagnostic approach. The addition of p16 was none-informative, but evaluation of its utility in larger series is warranted.

OriginalsprogEngelsk
TidsskriftPathology, research and practice
Vol/bind211
Udgave nummer1
Sider (fra-til)78-82
Antal sider5
ISSN0344-0338
DOI
StatusUdgivet - jan. 2015

ID: 44885147